SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-003000
Filing Date
2024-01-11
Accepted
2024-01-11 16:30:32
Documents
12
Period of Report
2024-01-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191520-8k_relmada.htm   iXBRL 8-K 27942
  Complete submission text file 0001213900-24-003000.txt   200390

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rlmd-20240105.xsd EX-101.SCH 3012
3 XBRL LABEL FILE rlmd-20240105_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rlmd-20240105_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT ea191520-8k_relmada_htm.xml XML 3326
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 24529571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)